Medicines linked to ED
Side effects of your regular medication may contribute to erectile dysfunction - check with your GP.
Regular tablets may be the cause
If you take medicine from the list below you should consult with your regular doctor before you start erectile dysfunction treatment. Adjusting your regular medication may help with erectile dysfunction. You should not stop medication before talking to your regular doctor.
Erectile dysfunction treatments are usually still effective even if medications from the list below are being taken at the same time.
Prescribed Medicines | Main use | Possible effect on sexual function |
---|---|---|
Antidepressants | ||
SSRI antidepressants (e.g. fluoxetine, sertraline, citalopram) | Depression, anxiety | Decreased sex drive, erectile dysfunction, delayed or absent orgasm, ejaculatory disturbances |
Tricyclic antidepressants (e.g. amitryptiline) | Depression, neuropathic pain, headaches | Decreased sex drive, erectile dysfunction, delayed or absent orgasm, ejaculatory disturbances |
Lithium | Depression, bipolar | Erectile dysfunction |
Phenelzine | Depression | Erectile dysfunction delayed or absent orgasm, ejaculatory disturbances |
Antiepileptics | ||
Carbamazepine | Epilepsy, trigeminal neuralgia | Erectile dysfunction |
Antihypertensives | ||
ACE inhibitors (e.g. ramipril, enalapril, lisinopril) | High blood pressure, heart failure | Decreased sex drive, erectile dysfunction |
Alpha-blockers (e.g. prazosin, doxazosin) | High blood pressure, enlarged prostate | Erectile dysfunction, ejaculatory disturbances |
Beta-blockers (e.g. atenolol, propranolol and including timolol eye drops) | High blood pressure, angina, glaucoma | Erectile dysfunction, decreased sex drive |
Calcium channel blockers (e.g. verapamil, nifedipine) | High blood pressure, angina | Erectile dysfunction |
Clonidine | High blood pressure | Erectile dysfunction, decreased sex drive |
Methyldopa | High blood pressure | Erectile dysfunction, decreased sex drive, ejaculatory failure |
Thiazide diuretics (e.g. bendroflumethiazide) | High blood pressure, heart failure, fluid retention | Erectile dysfunction |
Antipsychotics | ||
Haloperidol | Psychotic illness | Erectile dysfunction, decreased sex drive |
Risperidone | Psychotic illness | Erectile dysfunction, decreased sex drive, ejaculatory disturbances |
Olanzapine | Psychotic illness | Erectile dysfunction, decreased sex drive, ejaculatory disturbances |
Quetiapine | Psychotic illness | Erectile dysfunction |
Cholesterol lowering medicines | ||
Fibrates (e.g. clofibrate, gemfibrozil) | High cholesterol | Erectile dysfunction, decreased sex drive |
Statins (e.g. simvastatin) | High cholesterol | Erectile dysfunction |
Other | ||
Benzodiazepines | Anxiety, epilepsy | Decreased sex drive |
Cimetidine | Peptic ulcers, acid reflux disease | Decreased sex drive, erectile dysfunction |
Disulfiram | Alcohol withdrawal | Decreased sex drive |
Finasteride | Male pattern hair loss, enlarged prostate | Erectile dysfunction, decreased sex drive, ejaculation disorders, reduced quality of ejaculation |
Opioid painkillers (e.g. codeine, morphine) | Severe pain | Decreased sex drive, erectile dysfunction |
Prochlorperazine | Nausea and vomiting | Erectile dysfunction |
Spironolactone | Heart failure, fluid retention | Decreased sex drive |

Authored 12 July 2010 by
Dr Tony Steele
MB ChB Sheffield University 1983. Former hospital doctor and GP. GMC no. 2825328
Reviewed by
Dr C. Pugh,
Dr B. Babor,
Dr J. Tweedie
Last reviewed 4 June 2025
Last updated 20 August 2025
References
- BNF/NICE, 2025, PHENELZINE, accessed 3 June 2025
- BNF/NICE, 2025, SERTRALINE - Side-effects, accessed 3 June 2025
- Aurobindo Pharma - Milpharm, 2025, Citalopram 20mg Tablets: Summary of Product Characteristics - Undesirable effects, accessed 3 June 2025
- Flamingo Pharma, 2022, Fluoxetine 20 mg Capsules: Summary of Product Characteristics - Undesirable effects, accessed 3 June 2025
- Brown & Burk, 2025, Amitriptyline 10 mg Film-Coated Tablets: Summary of Product Characteristics - Undesirable effects, accessed 3 June 2025
- Novartis Pharmaceuticals, 2025, Tegretol Tablets 100mg, 200mg, 400mg: Summary of Product Characteristics - Undesirable effects, accessed 3 June 2025
- Aurobindo Pharma - Milpharm, 2023, Enalapril 5mg Tablets: Summary of Product Characteristics - Undesirable effects, accessed 3 June 2025
- Accord-UK, 2023, Ramipril 2.5mg Tablets: Summary of Product Characteristics - Undesirable effects, accessed 3 June 2025
- Aurobindo Pharma - Milpharm, 2020, Lisinopril 20mg Tablets: Summary of Product Characteristics - Undesirable effects, accessed 3 June 2025
- Pfizer, 2021, Hypovase Tablets 0.5mg: Summary of Product Characteristics - Undesirable effects, accessed 3 June 2025
- Aurobindo Pharma - Milpharm Ltd, 2024, Doxazosin 1mg Tablets: Summary of Product Characteristics - Undesirable effects, accessed 3 June 2025
- Strides Pharma, 2025, Atenolol 100 mg Tablets: Summary of Product Characteristics - Undesirable effects, accessed 4 June 2025
- FDC International, 2020, Timolol Eye Drops 0.25%: Summary of Product Characteristics - Undesirable effects, accessed 4 June 2025
- Aurobindo Pharma - Milpharm Ltd, 2023, Amlodipine 5mg tablets - Summary of Product Characteristics (SmPC) - (emc) | 4717, accessed 4 June 2025
- Sandoz, 2020, Clonidine 25mcg Tablets BP: Summary of Product Characteristics - Undesirable effects, accessed 4 June 2025
- Aspen, 2022, Methyldopa 250 mg Tablets BP: Summary of Product Characteristics - Undesirable effects, accessed 4 June 2025
- Sigma Pharmaceuticals PLC, 2024, Bendroflumethiazide 2.5mg Tablets - Summary of Product Characteristics (SmPC) - (emc) | 14971 accessed 4 June 2025
- EUMEDICA, 2018, Orap 4 mg tablets: Summary of Product Characteristics - Undesirable effects, accessed 4 June 2025
- Aurobindo Pharma - Milpharm, 2021, Risperidone 0.5 mg film-coated Tablets: Summary of Product Characteristics - Undesirable effects, accessed 4 June 2025
- Pinewood Healthcare, 2018, Haloperidol Oral Solution BP 5 mg/5 ml - Summary of Product Characteristics (SmPC) - (emc) | 4520 accessed 4 June 2025
- Aurobindo Pharma - Milpharm, 2023, Olanzapine 10 mg tablets - Summary of Product Characteristics (SmPC) - (emc) | 3070 accessed 4 June 2025
- BNF/NICE 2025, Quetiapine | Drugs | BNFC | NICE accessed 4 June 2025
- BNF/NICE, 2025, CIPROFIBRATE - Side-effects, accessed 4 June 2025
- Zentiva, 2021, Fenofibrate 267mg Capsules: Summary of Product Characteristics - Undesirable effects, accessed 4 June 2025
- Pfizer, 2024, Lopid 300 mg Hard Capsules: Summary of Product Characteristics - Undesirable effects, accessed 4 June 2025
- Aurobindo Pharma - Milpharm, 2025, Simvastatin 10mg Tablets: Summary of Product Characteristics - Undesirable effects, accessed 4 June 2025
- Sandoz Ltd, 2024, Diazepam 2 mg/5 ml Oral Suspension - Summary of Product Characteristics (SmPC) - (emc) | 7212, accessed 4 June 2025
- BNF/NICE, 2025, ATORVASTATIN - Side-effects, accessed 4 June 2025
- Brown & Burk, 2023, Disulfiram 200 mg tablets: Summary of Product Characteristics - Undesirable effects, accessed 4 June 2025
- Aurobindo Pharma - Milpharm, 2020, Finasteride 5mg Tablets: Summary of Product Characteristics - Undesirable effects, accessed 4 June 2025
- Essential Pharma, 2020, Camcolit 400 mg, controlled release Lithium Carbonate: Summary of Product Characteristics - Undesirable effects, accessed 4 June 2025
- Martindale Pharma, 2020, Morphine 10mg/5ml Oral Solution: Summary of Product Characteristics - Undesirable effects, accessed 4 June 2025
- Sanofi, 2022, Stemetil 5 mg Tablets - Summary of Product Characteristics (SmPC) - (emc) | 99, accessed 4 June 2025
- BNF/ NICE 2025, Spironolactone | Drugs | BNF | NICE, accessed 4 June 2025